This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Olanzapine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is a thienbenzodiazepine similar in structure to clozapine. Olanzapine has less affinity for D2-receptors than do conventional antipsychotics but more than clozapine. It binds strongly to several 5HT receptor subtypes and to histaminergic, muscurinic and alpha1- and alpha2- adrenergic.

Olanzapine is as effective as haloperidol at relieving symptoms of schizophrenia, but is less likely to cause extrapyrimidal symptoms. Olanzapine appears to be more effective than haloperidol in the treatment of negative symptoms of schizophrenia.

Drugs and Therapeutics bulletin in 1997 stated that. "..on present evidence, olanzapine is well worth trying in patients who have responded to conventional antipsychotics but who develop extrapyrimidal symptoms. Other possible advantages such as effects on negative symptoms need confirmation (1)."

Olanzapine has been given approval for the use in the treatment of moderate to severe manic episode (2). However olanzapine is not approved for the treatment of dementia-related psychosis and/or behavioural disturbances and is not recommended for use in this particular group of patients (3) - this guidance relates to safety information from clinical trials involving elderly patients treated with olanzapine where the patient group treated with olanzapine showed a two-fold increase in mortality compared with placebo and a three-fold increase in cerebrovascular events compared with placebo (3).

Please consult the summary of product characteristics before prescribing this drug.

Reference:

  1. Drugs and Therapeutics Bulletin (1997), 35(7),81-3.
  2. Eli Lilly and Company Limited (June 2002). Zyprexa (olanzapine) New indication for the treatment of moderate to severe manic episode.
  3. Eli Lilly and Company Limited (March 2nd 2004). Important Safety Information on olanzapine and risk of mortality and stroke in elderly patients with dementia-related psychosis and/or behavioural disturbances.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.